Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4011

Introduced
6/12/23  
Refer
6/12/23  

Caption

TACT Act of 2023 Timely Access to Clinical Treatment Act of 2023

Impact

If enacted, the TACT Act would significantly alter healthcare delivery systems related to oral medications by removing barriers for patients regarding prescription fulfillment. It specifically addresses delays typically caused by prior authorization processes and stipulates that health plans must cover prescriptions even from alternate providers if a pharmacy is unable to deliver on time. The bill aims to improve overall health outcomes by ensuring that patients have timely access to necessary medications, thereby reducing the period of uncertainty and potential health risks associated with delayed treatments.

Summary

House Bill 4011, also known as the Timely Access to Clinical Treatment Act of 2023 (TACT Act), proposes amendments to Title XXVII of the Public Health Service Act aimed at enhancing patient access to oral medications. The bill introduces requirements for health plans and insurance issuers concerning their contracts with pharmacies, stipulating that they must ensure timely dispensing of prescriptions for oral medications. Specifically, the bill mandates that pharmacies confirm their capability to fill a prescription within 24 hours and dispense the medication within a further defined timeframe, which enhances operational efficiencies in providing medication to patients.

Contention

Despite its goals, the implementation of HB4011 has sparked discussions around the feasibility of enforcing these regulations among various healthcare stakeholders. Critics argue that the stringent timelines may be unrealistic for pharmacies, especially smaller, independent ones that might lack the necessary resources to comply effectively. Furthermore, there are concerns about how these changes might impact cost-sharing calculations between pharmacies and health plans, as well as the potential for increased healthcare costs if not managed appropriately. Stakeholders are particularly interested in how the amendments will affect long-term patient care and medication adherence.

Companion Bills

No companion bills found.

Previously Filed As

US HB3561

PATIENT Act of 2023 Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023

US HB4822

Health Care Price Transparency Act of 2023

US HB4392

PrEP Access and Coverage Act of 2023

US HB4731

Access to Infertility Treatment and Care Act

US SB2386

Access to Infertility Treatment and Care Act

US SB2188

PrEP Access and Coverage Act of 2023

US HB2534

PROTECT 340B Act of 2023 Preserving Rules Ordered for The Entities Covered Through 340B Act of 2023

US HB8702

Improving Seniors’ Timely Access to Care Act of 2024

US HB1385

DOC Access Act of 2023 Dental and Optometric Care Access Act of 2023

US HB3134

Emergency Access to Insulin Act of 2023

Similar Bills

US SB1339

Pharmacy Benefit Manager Reform Act

US HB2679

Pharmacy Benefits Manager Accountability Act

US HB4822

Health Care Price Transparency Act of 2023

US SB1542

DRUG Act Delinking Revenue from Unfair Gouging Act

US HB2534

PROTECT 340B Act of 2023 Preserving Rules Ordered for The Entities Covered Through 340B Act of 2023

US HB4508

Hidden Fee Disclosure Act

US HB4895

Lowering Drug Costs for American Families Act

US HB4712

Patient Right to Shop Act